PR97842

GenScript Receives Best Cell & Gene Therapy Supplier Award: Gene Editing and GenScript ProBio Receives Best Biologics CMO Awards: Upstream Processing & Analytical Services

SINGAPORE, Sept. 15, 2022 /PRNewswire=KYODO JBN/ --

GenScript Biotech Corporation ("GenScript", Stock Code: 1548.HK) and

GenScriptProBio (a global one-stop CDMO from GenScript Group) receive 3 awards:

Best Cell & Gene Therapy Supplier Award – Gene Editing on the Asia-Pacific Cell

& Gene Therapy Excellence Awards (ACGTEA) and Best Biologics CMO Awards:

Upstream Processing and Analytical Services on the Asia Pacific Biologics CMO &

CDMO Excellence Awards (APBCEA) 2022. This is the first time for GenScript to

be recognized in these awards in Asia Pacific region.

"Cell and gene therapy is the forefront of innovation and the game changer to

bring lights for severe and rare disease patients. With our extensive

experiences and matured proprietary technologies for genome editing, we are

dedicated to provide the best gene editing services to help in target

identification and lead validation stages." said Dr. Leo Li during the award

ceremony. "This award is a solid testament for GenScript's 20 years of R&D

investment and experiences to provide gene editing service to our partners

globally. We are glad that our efforts have been recognized by the panel of

judges and peers and we will continue to strive for excellence."

Both the Asia-Pacific Cell & Gene Therapy Excellence Awards (ACGTEA) 2022

Biologics CMO & CDMO Excellence Awards 2022 recognizes exceptional

bioprocessing experts, CMO & CDMO organizations and technologies that

facilitate biomanufacturing and biologics manufacturing excellence at enhanced

speed, reduced cost, and superior quality. This year, GenScript and GenScript

ProBio have emerged as award winners for 3 awards.

"We are honored to be recognized by our customers and industry peers as the

leading biologics CMO service partner for upstream processing and analytical

services in Asia Pacific. This award recognizes our continuous effort and

dedication to maintain our global position as the top solutions and service

provider to accelerate drug development, next generation vaccines and

therapies", said Dr. Sharon Du, Director of Business Development, GenScript

ProBio Asia Pacific division. "Aside from upstream processes and analytical

services, GenScript Probio can provide downstream process development as well,

making it a one stop solution for customer. We will continue to provide the

best solution to our customers and partners by leveraging our technology

platforms and expertise."

About GenScript Biotech Corporation

GenScript Biotech Corporation (Stock Code: 1548.HK) is the world's leading

technology and service provider of life science R&D and manufacture. Built upon

its solid gene synthesis technology, GenScript Biotech is divided into four

major platforms including the life science service and product platform, the

biologics contract development and manufacturing organization (CDMO) platform,

the global cell therapy platform and the industrial synthesis biological

product platform.

GenScript Biotech was founded in New Jersey, US in 2002 and listed on the Hong

Kong Stock Exchange in 2015. GenScript Biotech's business operations span over

100countries and regions worldwide with legal entities located in the US,

Mainland China, Hong Kong, China, Japan, Singapore, the Netherlands and

Ireland. GenScript Biotech provides premium, convenient and reliable services

and products for over 100,000customers.

As of December31, 2021, GenScript Biotech had more than 5,200employees

globally, over 40% of whom hold master's and/or Ph.D. degrees. In addition,

GenScript Biotech owns a number of intellectual property rights, including over

180 patents, over 670pending patent applications and great numbers of trade

secrets.

Driven by the corporate mission of "making people and nature healthier through

biotechnology", GenScript Biotech strives to become the most trustworthy

biotech company in the world. As of December31,2021, GenScript Biotech's

services and products have been cited by 65,600peer-reviewed journal articles

worldwide.

For more information, please visit GenScript Biotech's official website.

https://www.genscript.com

About GenScript ProBio

GenScript ProBio is the subsidiary of GenScript Biotech Corporation,

proactively providing end-to-end CDMO service from drug discovery to

commercialization with proactive strategies, professional solutions and

efficient processes in cell and gene therapy (CGT), vaccine, biologics

discovery and antibody protein drug to accelerate drug development for

customers. GenScript ProBio has established companies in the United States, the

Netherlands, South Korea, Shanghai, Hong Kong, Nanjing and other places to

serve global customers, and supported customers in the United States, Europe,

Asia Pacific and other regions to obtain more than 30 IND approvals.

GenScript ProBio's total cell and gene therapy solution covers CMC of plasmid

and virus for IND filing as well as clinical manufacturing and commercial

manufacturing.

GenScript ProBio's innovative solutions for biologics discovery and development

include therapeutic antibody discovery, antibody engineering and antibody

characterization. In biologics development service, GenScript ProBio has built

a DNA to GMP material platform, including stable cell line development, host

cell license, process development, analytical development to clinical

manufacturing, and offer fed-batch and perfusion process to meet the growing

needs for antibody and protein drugs. GenScript ProBio has established GMP

capacity which meets FDA, EMA and NMPA regulatory requirements.

Toward the mission of "Innovation through Collaboration", GenScript ProBio is

committed to helping customers shorten the timeline for the development of

biological drugs from discovery to commercialization, significantly lowering

R&D costs and building a healthier future.

https://www.genscriptprobio.com/

SOURCE: GenScript; GenScript ProBio

Image Attachments Links:

   Link: http://asianetnews.net/view-attachment?attach-id=429441

   Caption: Dr. Leo Li, Marketing Director of GenScript Asia Pacific division receiving the

Best Cell & Gene Therapy Supplier Award on the ACGTEA awards ceremony.

   Link: http://asianetnews.net/view-attachment?attach-id=429443

   Caption: Dr. Sharon Du, Business Development Director of GenScript ProBio receiving the

Best Biologics CMO Awards: Upstream Processing & Analytical Services on the

APBCEA awards ceremony.